1-4 of 4
Stefan J. Scherer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib

Michael F. Press, Catherine E. Ellis, Robert C. Gagnon, Tobias J. Grob, Marc Buyse, Ivonne Villalobos, Zhiyong Liang, Shafei Wu, Yung-Jue Bang, Shu-Kui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Karen Afenjar, Yanling Ma, Monica C. Estrada, Douglas M. Robinson, Stefan J. Scherer, Guido Sauter, J. Randolph Hecht, Dennis J. Slamon
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (1): 228–238.
https://doi.org/10.1158/1535-7163.MCT-15-0887
Published: 05 January 2017
View articletitled, HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
Open the PDF for HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib in another window
Includes: Supplementary data
Journal Articles

Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection

Stefan Stremitzer, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Satoshi Matsusaka, Anish Parekh, Satoshi Okazaki, Diana Hanna, Stephanie H. Astrow, Miriana Moran, Jose Hernandez, Craig Stephens, Stefan J. Scherer, Judith Stift, Friedrich Wrba, Thomas Gruenberger, Heinz-Josef Lenz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (11): 2814–2821.
https://doi.org/10.1158/1535-7163.MCT-16-0275
Published: 01 November 2016
View articletitled, Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Open the PDF for Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection in another window
Includes: Supplementary data
Journal Articles

Abstract LB-A05: Profiling cell free DNA in breast cancer and non-small cell lung cancer using broad NGS assessment

Nadia Solovieff, Matt Hims, Rebecca Leary, Derek Chiang, Caroline Germa, Cristian Massacesi, Samit Hirawat, Stefan J. Scherer, Michael Morrissey, Wendy Winckler, Emmanuelle di Tomaso
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-A05.
https://doi.org/10.1158/1535-7163.TARG-15-LB-A05
Published: 01 December 2015
View articletitled, Abstract LB-A05: Profiling cell free DNA in breast cancer and non-small cell lung cancer using broad NGS assessment
Journal Articles

Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing

Dror Alishekevitz, Rotem Bril, David Loven, Valeria Miller, Tali Voloshin, Svetlana Gingis-Velistki, Ella Fremder, Stefan J. Scherer, Yuval Shaked
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (1): 202–213.
https://doi.org/10.1158/1535-7163.MCT-13-0356
Published: 13 January 2014
View articletitled, Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
Open the PDF for Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing in another window
Includes: Supplementary data